As of 12:33pm ET
| -0.0099 / -0.63%|
The 3 analysts offering 12-month price forecasts for Rexahn Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 19.50 and a low estimate of 6.00. The median estimate represents a +727.97% increase from the last price of 1.57.
The current consensus among 3 polled investment analysts is to Buy stock in Rexahn Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.